These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15897887)

  • 1. Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes.
    Grützmann R; Boriss H; Ammerpohl O; Lüttges J; Kalthoff H; Schackert HK; Klöppel G; Saeger HD; Pilarsky C
    Oncogene; 2005 Jul; 24(32):5079-88. PubMed ID: 15897887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
    Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
    Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially expressed genes by meta-analysis of microarray data on breast cancer.
    Kondrakhin YV; Sharipov RN; Keld AE; Kolpakov FA
    In Silico Biol; 2008; 8(5-6):383-411. PubMed ID: 19374127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.
    Sato N; Maitra A; Fukushima N; van Heek NT; Matsubayashi H; Iacobuzio-Donahue CA; Rosty C; Goggins M
    Cancer Res; 2003 Jul; 63(14):4158-66. PubMed ID: 12874021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression.
    Ryu B; Jones J; Blades NJ; Parmigiani G; Hollingsworth MA; Hruban RH; Kern SE
    Cancer Res; 2002 Feb; 62(3):819-26. PubMed ID: 11830538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selection of genes related to multidrug resistance of pancreatic ductal adenocarcinoma by microarray analysis].
    Feng B; Zhao YP; Chen G; Zhang TP; Wu YD
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(23):1629-33. PubMed ID: 18453221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray.
    Johnson SK; Dennis RA; Barone GW; Lamps LW; Haun RS
    Mol Carcinog; 2006 Nov; 45(11):814-27. PubMed ID: 16865675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.
    Badea L; Herlea V; Dima SO; Dumitrascu T; Popescu I
    Hepatogastroenterology; 2008; 55(88):2016-27. PubMed ID: 19260470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells.
    Youns M; Efferth T; Reichling J; Fellenberg K; Bauer A; Hoheisel JD
    Biochem Pharmacol; 2009 Aug; 78(3):273-83. PubMed ID: 19393226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross platform microarray analysis for robust identification of differentially expressed genes.
    Bosotti R; Locatelli G; Healy S; Scacheri E; Sartori L; Mercurio C; Calogero R; Isacchi A
    BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S5. PubMed ID: 17430572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction and primary application of oligonucleotide microarray specialized for pancreatic adenocarcinoma-associated genes].
    Shi X; Wei WJ; Gao NR; Cheng ZJ; Tang YH
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):39-42. PubMed ID: 17403288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gamma-aminobutyric acid A receptor pi subunit is overexpressed in pancreatic adenocarcinomas.
    Johnson SK; Haun RS
    JOP; 2005 Mar; 6(2):136-42. PubMed ID: 15767729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
    Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
    Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmation of DNA microarray-derived differentially expressed genes in pancreatic cancer using quantitative RT-PCR.
    Streit S; Michalski CW; Erkan M; Friess H; Kleeff J
    Pancreatology; 2009; 9(5):577-82. PubMed ID: 19657213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
    Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR
    J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer.
    Zhao YP; Chen G; Feng B; Zhang TP; Ma EL; Wu YD
    Chin Med J (Engl); 2007 Oct; 120(20):1743-52. PubMed ID: 18028764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.